Shares of Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) were down 13% during mid-day trading on Monday . The stock traded as low as GBX 1.70 ($0.02) and last traded at GBX 1.70 ($0.02). Approximately 80,437 shares changed hands during mid-day trading, a decline of 95% from the average daily volume of 1,541,478 shares. The stock had previously closed at GBX 1.96 ($0.02).
Cizzle Biotechnology Price Performance
The business has a 50-day moving average of GBX 1.81 and a 200 day moving average of GBX 1.85. The company has a market capitalization of £7.29 million, a PE ratio of -2,581.64 and a beta of 0.38.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
See Also
- Five stocks we like better than Cizzle Biotechnology
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- 3 Industry Leading Stocks Just Raised Dividends by 10% or More
- What is MarketRank™? How to Use it
- Twilio, Braze: The Top 2 CEP Platforms to Own in 2025
- Insider Trading – What You Need to Know
- Tempus AI Is a Buy, If You Can Handle the Volatility
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
